Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories has announced a forthcoming Board of Directors meeting on July 27, 2024, to discuss and approve the company’s unaudited financial results for the quarter ending June 30, 2024. Additionally, in compliance with SEBI regulations, the company has declared a trading window closure for its securities from June 24 to July 29, 2024.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
